'Generic Drugs Are Experiencing Faster Sales Growth Than Many Branded Ones, and This Trend is Set to Continue', Says visiongain.SAN FRANCISCO San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden & LONDON London, city, Canada London, city (1991 pop. 303,165), SE Ont., Canada, on the Thames River. The site was chosen in 1792 by Governor Simcoe to be the capital of Upper Canada, but York was made capital instead. London was settled in 1826. -- Generic pharmaceutical products are becoming an ever important part of the major pharmaceutical markets. In fact in 2004 the total world market for generic prescription drugs prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, was $39.6bn and it is set to rise to $83.9bn by 2010. These are the findings of visiongain's latest report "The World's Top Ten Generic Companies 2005". With over 39 major drugs due to lose their patent protection before 2010, generic companies are prepared to gain even further market share. Visiongain predicts that there will be sustained increases in growth through 2005-2007, but that there will be a peak in the period 2008-2010. Visiongain also reveals that nine of the top ten fastest growing pharmaceutical companies are generic as a result of the increasing demand for cheaper drugs. This high growth market is especially important as branded drug growth rates Growth Rates The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures. Notes: Remember, historically high growth rates don't always mean a high rate of growth looking into the future. are beginning to falter for the same forecast period. Report author Dr Gordon Low said: "It is a constantly changing market with companies merging to improve overall competitive position." The study examines crucial aspects of the top ten generic companies, including recent acquisitions and mergers as well as the latest financial results of each. The report also covers the latest generic company strategies, the success and failure of the Hatch-Waxman Act, European European emanating from or pertaining to Europe. European bat lyssavirus see lyssavirus. European beech tree fagussylvaticus. European blastomycosis see cryptococcosis. regulatory issues, and important litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. in the sector. ENDS Notes for editors: To receive your complimentary overview of this report please send an email to Sara Peerun sara.peerun@visiongain.com, telephone Sara on +44 (0) 20 8767 6711 or visit the media section on www.visiongainintelligence.com. Please include your full name, title of publication, contact telephone number, email, and details of where you saw this release. Upon receipt of this information, an overview will be emailed to you. Background: Visiongain is one of the fastest growing and most innovative independent media companies in Europe today Europe Today is a daily radio news show on the BBC World Service about public affairs throughout Europe. It is presented by Audrey Carville at 17:00 GMT every weekday. External links
For information on visiongain, please visit www.visiongain.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion